Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study
Background: The clinical impact of the functional CYP2C19 and CYP2D6 gene variants on antidepressant treatment in people with depression is not well studied. Here, we evaluate the utility of pharmacogenetic (PGx) testing in psychiatry by investigating the association between the phenotype status of...
Main Authors: | Liv S. Thiele, Kazi Ishtiak-Ahmed, Janne P. Thirstrup, Esben Agerbo, Carin A. T. C. Lunenburg, Daniel J. Müller, Christiane Gasse |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/7/870 |
Similar Items
-
Clinical impact of functional CYP2C19 and CYP2D6 gene variants on treatment outcomes in patients with depression: a Danish cohort study
by: L. Thiele, et al.
Published: (2022-06-01) -
Pharmacogenetics and antidepressant treatment outcomes in pregnancy: a Danish-population based study
by: M. Mushtaq, et al.
Published: (2022-06-01) -
Pharmacogenetics and adhd treatment outcomes in the danish population-based IPSYCH sample
by: C. Lunenburg, et al.
Published: (2021-04-01) -
Pharmacogenetic drug use in young danish individuals with severe mental disorders
by: C. Lunenburg, et al.
Published: (2021-04-01) -
Pharmacogenetic profiles of young danish individuals with and without severe mental disorders
by: C. Lunenburg, et al.
Published: (2021-04-01)